Konecny GE, Oza AM, Tinker AV, Oaknin A, et al. Population exposure-efficacy and exposure-safety analyses for rucaparib in patients with recurrent ovarian carcinoma from Study 10 and ARIEL2. Gynecol Oncol 2021 Mar 19. pii: S0090-8258(21)00235.
PMID: 33752918